Patient groups' views on the use of health apps, including those produced or developed by pharma companies. -WHAT PATIENT GROUPS SAID ABOUT HEALTH APPS (INCLUDING THOSE OF PHARMA)-
In April-May 2017 PatientView was commissioned by Deloitte UK Centre for Health solutions to conduct a survey regarding the use of health apps, including those produced or developed by pharma companies. The primary objective of the survey was to map the patient usage of health apps and determine patient group views of the usefulness of pharma health apps. 190 patient groups responded to the survey, representing 56 therapy areas from 38 countries. A summary of the results is available on PatientView's website; the final Deloitte report and blog results are available on Deloitte's website. Just click on the buttons below to download the information you need. |